Amir Mohamed Abdelhamid
Overview
Explore the profile of Amir Mohamed Abdelhamid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdelhamid A, Saber S, Hamad R, Abdel-Reheim M, Ellethy A, Amer M, et al.
Front Pharmacol
. 2024 Sep;
15:1454829.
PMID: 39309001
Introduction: Liver fibrosis is a significant global health burden that lacks effective therapies. It can progress to cirrhosis and hepatocellular carcinoma (HCC). Aberrant hedgehog pathway activation is a key driver...
2.
Ali N, Abdelhamid A, El-Sayed N, Radwan A
Toxicol Appl Pharmacol
. 2024 Jul;
490:117041.
PMID: 39059505
Alcoholic liver disease (ALD) is a major cause of chronic liver injury characterized by steatosis, inflammation, and fibrosis. This study explored the hepatoprotective mechanisms of alpha-asarone in a mouse model...
3.
Cavalu S, Saber S, Amer A, Hamad R, Abdel-Reheim M, Elmorsy E, et al.
FASEB J
. 2024 Jul;
38(13):e23813.
PMID: 38976162
Beta-blockers are commonly used medications that antagonize β-adrenoceptors, reducing sympathetic nervous system activity. Emerging evidence suggests that beta-blockers may also have anticancer effects and help overcome drug resistance in cancer...
4.
Cavalu S, Abdelhamid A, Saber S, Elmorsy E, Hamad R, Abdel-Reheim M, et al.
FASEB J
. 2024 Jun;
38(11):e23734.
PMID: 38847486
The cell cycle is tightly regulated to ensure controlled cell proliferation. Dysregulation of the cell cycle machinery is a hallmark of cancer that leads to unchecked growth. This review comprehensively...
5.
Ciorba A, Roiu G, Abdelhamid A, Saber S, Cavalu S
Diagnostics (Basel)
. 2023 Mar;
13(6).
PMID: 36980422
The aim of this study was to evaluate the influence of phacoemulsification cataract surgery on the state of the corneal endothelium in diabetic versus non-diabetic patients. We compared the corneal...
6.
Saber S, Abd El-Fattah E, Abdelhamid A, Mourad A, Hamouda M, Elrabat A, et al.
Biomed Pharmacother
. 2023 Mar;
158:114196.
PMID: 36916405
Hepatocellular carcinoma (HCC) is the third foremost cause of cancer-related deaths. HCC has a very bad prognosis because it is asymptomatic in the early stages, resulting in a late diagnosis,...
7.
Nasr M, Cavalu S, Saber S, Youssef M, Abdelhamid A, Elagamy H, et al.
Biomed Pharmacother
. 2022 Sep;
153:113409.
PMID: 36076534
Ulcerative colitis is an idiopathic disease that is widely incident worldwide. Canagliflozin, antidiabetic agent, exhibited significant anti-inflammatory effects in a variety of animal models. Additionally, hyaluronic acid is considered one...
8.
Cavalu S, Sharaf H, Saber S, Youssef M, Abdelhamid A, Mourad A, et al.
FASEB J
. 2022 Aug;
36(9):e22496.
PMID: 35947115
Ulcerative colitis (UC) is a chronic inflammatory bowel disease of unknown etiology that increases the risk of developing colorectal cancer and imposes a lifelong healthcare burden on millions of patients...
9.
Abdelhamid A, Youssef M, Cavalu S, Mostafa-Hedeab G, Youssef A, Elazab S, et al.
Front Pharmacol
. 2022 Jun;
13:887233.
PMID: 35754464
Ulcerative colitis (UC), an inflammatory bowel disease, is a chronic condition of a multifaceted pathophysiology. The incidence of UC is increasing internationally. The current therapies for UC lack relative effectiveness...
10.
Shaaban A, Abdelhamid A, Shaker M, Cavalu S, Maghiar A, Alsayegh A, et al.
Biomed Pharmacother
. 2022 Jun;
153:113247.
PMID: 35724510
Ulcerative colitis (UC) is a prevalent type of inflammatory bowel diseases that may predispose patients to acquire colitis-related cancer if treatment was not effective. Despite the presence of an array...